TRCT
NKTX icon

Tower Research Capital (TRC)’s Nkarta NKTX Stock Holding History

Tower Research Capital (TRC)’s Portfolio NKTX Stock Details NKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.1K Sell
5,239
-4,219
-45% -$9.44K ﹤0.01% 3859
2025
Q4 		$17.5K Sell
9,458
-2,516
-21% -$5.03K ﹤0.01% 3201
2025
Q3 		$24.8K Sell
11,974
-8,385
-41% -$17.2K ﹤0.01% 3107
2025
Q2 		$33.8K Buy
20,359
+10,073
+98% +$18.5K ﹤0.01% 3313
2025
Q1 		$18.9K Buy
10,286
+3,215
+45% +$6.59K ﹤0.01% 3027
2024
Q4 		$17.6K Buy
7,071
+2,656
+60% +$8.2K ﹤0.01% 3300
2024
Q3 		$20K Buy
4,415
+1,396
+46% +$7.93K ﹤0.01% 3239
2024
Q2 		$17.8K Buy
3,019
+672
+29% +$4.75K ﹤0.01% 3816
2024
Q1 		$25.4K Sell
2,347
-2,293
-49% -$23.8K ﹤0.01% 2790
2023
Q4 		$30.6K Sell
4,640
-6,114
-57% -$15.8K ﹤0.01% 3412
2023
Q3 		$14.9K Buy
10,754
+3,438
+47% +$6.52K ﹤0.01% 3645
2023
Q2 		$16K Buy
7,316
+5,070
+226% +$22.3K ﹤0.01% 3587
2023
Q1 		$8K Sell
2,246
-551
-20% -$2.61K ﹤0.01% 4644
2022
Q4 		$17K Buy
2,797
+1,149
+70% +$11.6K ﹤0.01% 3283
2022
Q3 		$22K Sell
1,648
-5,074
-75% -$72.6K ﹤0.01% 3866
2022
Q2 		$83K Sell
6,722
-7,871
-54% -$103K ﹤0.01% 2437
2022
Q1 		$166K Buy
14,593
+12,918
+771% +$138K ﹤0.01% 1862
2021
Q4 		$26K Sell
1,675
-1,033
-38% -$17.7K ﹤0.01% 3390
2021
Q3 		$75K Buy
2,708
+913
+51% +$28.9K ﹤0.01% 2637
2021
Q2 		$57K Sell
1,795
-230
-11% -$6.63K ﹤0.01% 2915
2021
Q1 		$67K Buy
2,025
+1,617
+396% +$77.3K ﹤0.01% 2883
2020
Q4 		$25K Sell
408
-2,189
-84% -$90.9K ﹤0.01% 3724
2020
Q3 		$78K Buy
+2,597
New +$76.5K ﹤0.01% 3324

Other funds holding NKTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
GP
GSK plc London $599M AUM
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Tower Research Capital (TRC)'s NKTX Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Nkarta (NKTX) stake by 45% in Q1 2026, selling an estimated $9.44K and leaving 5,239 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3859.

Tower Research Capital (TRC) first reported a position in NKTX in Q3 2020 and has held it in 23 quarters since. The position peaked at $166K in Q1 2022. 126 funds tracked by Wall St. Rank hold NKTX as of Q1 2026.

  • Tower Research Capital (TRC) held 5,239 shares of Nkarta worth $11.1K as of Q1 2026.
  • Tower Research Capital (TRC) sold 4,219 Nkarta shares in Q1 2026, an estimated $9.44K.
  • Nkarta made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3859 holding.
  • Tower Research Capital (TRC) first reported a position in Nkarta in Q3 2020 and has held it in 23 quarters since.
  • Tower Research Capital (TRC)'s Nkarta position peaked at $166K in Q1 2022.
  • 126 funds tracked by Wall St. Rank held Nkarta as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.